A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2
A protein-based vaccine against SARS-CoV-2 has been developed.
It is based on the spike protein containing a modified receptor binding domain (cRBD) with a set of engineered mutations.
It provides broad protection against various SARS-CoV-2 variants.